Don't Wait to Diagnose AMD
Are your patients going undiagnosed?
Age-related macular degeneration (AMD) is the leading cause of adult blindness in developed countries. In fact, AMD is three times more prevalent than glaucoma. And the problem is only expected to grow as the population ages.
A 2017 study published in JAMA Ophthalmology estimates there are currently 14 million patients with AMD in the U.S. But even with regular exams using current imaging tools, an additional 25% are undiagnosed.1 What does that 25% mean to your practice?
I have been in eye care since the late 90s and I remember that macular degeneration was just a condition that was very difficult to detect and even once detected, difficult to do anything about it. So essentially we were just watching patients go blind. Now that we have the AdaptDx it’s made a world of a difference in diagnosing patients.
Stages of AMD
As a progressive disease, AMD reveals itself in stages. Detecting AMD at the subclinical level offers patients the best chance to prevent blindness.
Symptoms & Risk Factors
Understanding the symptoms and risk factors will help identify AMD earlier.
AMD Testing Options
Is your practice making the best use of the available AMD testing methods?
Starting treatment of AMD early helps delay or prevent blindness.